Skip to main content
OpenTrials

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,456 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

Study Of Allergic Rhinitis In Patients Who Also Have Asthma

NCT00296491

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +10 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
View all 121 locations
View Trial Details
Completed

Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.

NCT00600171

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Huntington Beach, California, United States
View all 89 locations
View Trial Details
Completed

A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma

NCT00441441

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Riverside, California, United States
View all 55 locations
View Trial Details
Completed

A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis

NCT00609674

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Wheaton, Maryland, United States
  • GSK Investigational Site North Dartmouth, Massachusetts, United States
  • GSK Investigational Site Minneapolis, Minnesota, United States
View all 37 locations
View Trial Details
Completed

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

NCT01444430

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Huntsville, Alabama, United States
  • Research Site Anchorage, Alaska, United States
  • Research Site Gilbert, Arizona, United States
View all 340 locations
View Trial Details
Completed

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

NCT00519636

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 28 locations
View Trial Details
Completed

Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

NCT00539006

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 24 locations
View Trial Details
Completed

A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma

NCT00452348

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Fresno, California, United States
View all 81 locations
View Trial Details

Related conditions